Pyxis Oncology, Inc.
PYXS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782223
In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Pyxis Oncology, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +16 vs. Q4 2022
- Shares held
- 10.4M
- −9.41M (−47.6%) vs. Q4 2022
- Total value
- $41.5M
- +$15.0M (+56.8%) vs. Q4 2022
- New holders
- 24
- 8 more added
- Sold out
- 8
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 76 | $101.1M |
| Q1 2026 | 78 | $40.5M |
| Q4 2025 | 79 | $34.7M |
| Q3 2025 | 73 | $59.7M |
| Q2 2025 | 74 | $30.2M |
| Q1 2025 | 89 | $29.6M |
| Q4 2024 | 99 | $49.2M |
| Q3 2024 | 92 | $102.3M |
| Q2 2024 | 80 | $93.1M |
| Q1 2024 | 71 | $97.7M |
| Q4 2023 | 51 | $15.8M |
| Q3 2023 | 54 | $15.4M |
| Q2 2023 | 48 | $24.6M |
| Q1 2023 | 47 | $41.5M |
| Q4 2022 | 31 | $26.5M |
| Q3 2022 | 38 | $38.3M |
| Q2 2022 | 39 | $47.7M |
| Q1 2022 | 45 | $76.1M |
| Q4 2021 | 51 | $199.9M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Pyxis Oncology, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 3,170,803 | $12.7M | 0.57% | 00.0% | Unchanged |
| Tang Capital Management LLC | 2,481,662 | $9.95M | 1.48% | −989,038−28.5% | Reduced |
| Vanguard Group Inc | 1,062,549 | $4.26M | 0.00% | +144,722+15.8% | Added |
| Tekla Capital Management LLC | 708,303 | $2.84M | 0.11% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 530,692 | $2.13M | 0.04% | −233,714−30.6% | Reduced |
| Cormorant Asset Management, LP | 272,537 | $1.09M | 0.07% | −396,317−59.3% | Reduced |
| Point72 Asset Management, L.P. | 251,800 | $1.01M | 0.00% | +251,800 | New |
| Geode Capital Management, LLC | 239,351 | $959.8K | 0.00% | +35,417+17.4% | Added |
| BlackRock Inc. | 212,288 | $851.3K | 0.00% | +956+0.5% | Added |
| Bridgeway Capital Management, LLC | 170,295 | $682.9K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 168,576 | $676.0K | 0.00% | +62,157+58.4% | Added |
| Barclays PLC | 118,223 | $474.1K | 0.00% | −829,828−87.5% | Reduced |
| Renaissance Technologies LLC | 94,200 | $378.0K | 0.00% | +10,600+12.7% | Added |
| Harvest Investment Services, LLC | 91,047 | $365.1K | 0.28% | +91,047 | New |
| Jane Street Group, LLC | 75,430 | $302.5K | 0.00% | +75,430 | New |
| Royal Bank of Canada | 72,545 | $291.0K | 0.00% | +72,545 | New |
| ExodusPoint Capital Management, LP | 70,000 | $281.0K | 0.00% | +70,000 | New |
| HRT Financial LP | 69,782 | $279.0K | 0.00% | +69,782 | New |
| State Street Corp | 62,289 | $249.8K | 0.00% | 00.0% | Unchanged |
| University of Chicago | 48,731 | $195.4K | 0.09% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 37,945 | $152.2K | 0.00% | +37,945 | New |
| Goldman Sachs Group Inc | 35,424 | $142.1K | 0.00% | +35,424 | New |
| Acadian Asset Management LLC | 32,506 | $130.0K | 0.00% | −39,196−54.7% | Reduced |
| Northern Trust Corp | 31,507 | $126.3K | 0.00% | +5,109+19.4% | Added |
| Citadel Advisors LLC | 27,129 | $108.8K | 0.00% | −1,535,669−98.3% | Reduced |
| Deutsche Bank AG | 25,000 | $100.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 23,492 | $94.2K | 0.00% | −40,103−63.1% | Reduced |
| Kingsview Wealth Management, LLC | 20,000 | $80.2K | 0.00% | +20,000 | New |
| Sawtooth Solutions, LLC | 18,110 | $72.6K | 0.00% | +18,110 | New |
| Bleakley Financial Group, LLC | 18,110 | $72.6K | 0.00% | +18,110 | New |
| Charles Schwab Investment Management Inc | 17,739 | $71.1K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 13,768 | $55.2K | 0.00% | +13,768 | New |
| Tudor Investment Corp Et Al | 13,624 | $55.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 13,664 | $54.8K | 0.00% | +13,664 | New |
| Dimensional Fund Advisors LP | 12,087 | $48.5K | 0.00% | +12,087 | New |
| Tower Research Capital LLC (TRC) | 10,866 | $43.0K | 0.00% | +4,688+75.9% | Added |
| Advisor Group Holdings, Inc. | 8,000 | $32.1K | 0.00% | +8,000 | New |
| Bank of Montreal | 10,000 | $29.6K | 0.00% | +10,000 | New |
| JPMorgan Chase & Co | 5,033 | $20.0K | 0.00% | +5,033 | New |
| UBS Group AG | 2,955 | $11.8K | 0.00% | +2,955 | New |
| Point72 Middle East FZE | 2,447 | $9.81K | 0.00% | +2,447 | New |
| Wells Fargo & Company | 2,163 | $8.67K | 0.00% | +2,003+1,251.9% | Added |
| Cubist Systematic Strategies, LLC | 1,569 | $6.29K | 0.00% | +1,569 | New |
| GWM Advisors LLC | 250 | $1.00K | 0.00% | +250 | New |
| Coston, McIsaac & Partners | 383 | $1.00K | 0.00% | +383 | New |
| The PNC Financial Services Group, Inc. | 100 | $401 | 0.00% | +100 | New |
| West Branch Capital LLC | 25 | $101 | 0.00% | +25 | New |
| BVF Inc | 0 | $0 | 0.00% | −2,938,851−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −848,252−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −669,158−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −357,537−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −58,862−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −35,477−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −31,334−100.0% | Sold out |